Found: 7
Select item for more details and to access through your institution.
The peroxisome proliferator-activated receptor agonist pioglitazone and 5-lipoxygenase inhibitor zileuton have no effect on lung inflammation in healthy volunteers by positron emission tomography in a single-blind placebo-controlled cohort study.
- Published in:
- PLoS ONE, 2018, v. 13, n. 2, p. 1, doi. 10.1371/journal.pone.0191783
- By:
- Publication type:
- Article
Practice Patterns for Screening and Treating Interstitial Lung Disease–related Pulmonary Hypertension at Specialty Care Centers in the United States.
- Published in:
- 2024
- By:
- Publication type:
- Letter
A Phase II Clinical Trial of an Aromatase Inhibitor for Postmenopausal Women with Lymphangioleiomyomatosis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Expert consensus on the management of adverse events and prescribing practices associated with the treatment of patients taking pirfenidone for idiopathic pulmonary fibrosis: a Delphi consensus study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Upregulation of elastin expression in constrictive bronchiolitis obliterans.
- Published in:
- International Journal of COPD, 2007, v. 2, n. 4, p. 593
- By:
- Publication type:
- Article
Chemokine Receptor 2-targeted Molecular Imaging in Pulmonary Fibrosis. A Clinical Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Mechanisms of Remodeling in Asthmatic Airways.
- Published in:
- Journal of Allergy, 2012, p. 1, doi. 10.1155/2012/316049
- By:
- Publication type:
- Article